COLLPLANT BIOTECHNOLOGIES LT (CLGN) Stock Balance Sheet
NASDAQ:CLGN - Nasdaq - IL0004960188 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | 0.00 | 30.15M | N/A | |||
| Cash Equivalents | 11.91M | 26.67M | 29.65M | 13.15M | 3.33M | |||
| Receivables | 583.00K | 393.00K | 550.00K | 690.00K | 1.07M | |||
| Inventories | 440.00K | 714.00K | 1.43M | 1.08M | 1.26M | |||
| Other Current Assets | 248.00K | 241.00K | 20.00K | 10.00K | 10.00K | |||
| Total Current Assets | 13.18M | 28.02M | 31.66M | 45.09M | 5.68M | |||
| Non-Current Assets | ||||||||
| PPE Net | 5.28M | 5.86M | 5.68M | 5.68M | 4.90M | |||
| Intangibles | 131.00K | 188.00K | 250.00K | 240.00K | 80.00K | |||
| Other Non-Current Assets | 118.00K | 57.00K | 190.00K | 210.00K | 180.00K | |||
| Total Non-Current Assets | 5.53M | 6.10M | 6.11M | 6.13M | 5.16M | |||
| TOTAL ASSETS | 18.71M | 34.13M | 37.77M | 51.22M | 10.84M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 2.10M | 2.27M | 1.97M | 1.95M | 440.00K | |||
| Accounts Payable | 870.00K | 980.00K | 1.13M | 1.03M | 2.74M | |||
| Other Current Liabilities | N/A | N/A | 0.00 | 30.00K | 210.00K | |||
| Total Current Liabilities | 2.97M | 3.25M | 3.11M | 3.01M | 3.39M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 2.27M | 2.54M | 2.38M | 3.09M | 2.98M | |||
| Total Non-Current Liabilities | 2.27M | 2.54M | 2.38M | 3.09M | 2.97M | |||
| TOTAL LIABILITIES | 5.25M | 5.79M | 5.49M | 6.10M | 6.36M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -113.35M | -96.74M | -89.72M | -72.80M | -73.03M | |||
| Additional Paid In Capital | 122.80M | 121.07M | 118.10M | 114.22M | 75.55M | |||
| Common Shares | 4.98M | 4.98M | 4.87M | 4.66M | 2.93M | |||
| Other Shareholders' Equity | -969.00K | -969.00K | -970.00K | -970.00K | -970.00K | |||
| Shares Outstanding | 11.45M | 11.45M | 11.19M | 10.77M | 6.96M | |||
| Tangible Book Value per Share | 1.16 | 2.46 | 2.86 | 4.17 | 0.63 | |||
| Total Shareholders' Equity | 13.46M | 28.34M | 32.28M | 45.12M | 4.48M | |||
| TOTAL LIABILITIES AND EQUITY | 18.71M | 34.13M | 37.77M | 51.22M | 10.84M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 4.44 | 8.62 | 10.18 | 14.98 | 1.68 | |||
| Return On Assets (ROA) | -88.77% | -20.57% | -44.82% | 0.47% | -53.23% | |||
| Return On Equity (ROE) | -123.35% | -24.77% | -52.45% | 0.53% | -128.79% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | 0.72% | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | 0.99% | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | N/A | N/A | 1.00% | N/A | |||
All data in USD , ROIC based on taxRate of 0.21